How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

The super app is the oldest trick in the technology playbook. OpenAI is staking its IPO valuation on AI to make it work.

ReactOS open source Windows clone ran Half-Life in-game for the first time in 30 years of development. A March 2026 GPU ...

They explore how automation, AI, and integrated platforms are helping finance teams tackle today’s biggest challenges, from ...

Recently, the concept of so-called covenants has received renewed attention as Bitcoin development and protocol discussions underwent a renaissance. Covenants could enable and facilitate a wide range ...

Vibe-coding is revolutionizing software development and making it easier than ever to build fully functional websites and ...

The No. 45 company on the 2025 Inc. 5000 may be signing AI contracts far faster than Wall Street expected. Financing the ...

AbCellera has an AI-driven antibody discovery platform, $650M liquidity, and an upcoming Phase 2 catalyst. Click here to read ...

European tech activity in May 2026 was characterised by a decline in deal volume but a substantial increase in capital raised ...

Quantum materials are a class of exotic materials with special properties that are governed by quantum mechanics rather than ...

The "burned haystack" method means quickly eliminating potential dates with clear red flags. Blocking, instead of just ...

The Escalating Demand for a Business Insolvency Risk Assessment Given the current economic landscape in the UK—characterized by persistent inflation and post-Brexit market shifts—corporate failure ...